IPF-Acute Exacerbations: Advances and Future Perspectives

Overview

Journal Front Pharmacol

Date 2022 May 2

PMID 35496286

Authors

Spyros A Papiris

Lykourgos Kolilekas

Konstantinos Kagouridis

Maria Maniati

Effrosyni D Manali

Affiliations

Soon will be listed here.

References

Papiris S, Manali E, Kolilekas L, Triantafillidou C, Tsangaris I, Kagouridis K . Steroids in idiopathic pulmonary fibrosis acute exacerbation: defenders or killers?. Am J Respir Crit Care Med. 2012; 185(5):587-8. DOI: 10.1164/ajrccm.185.5.587. View

ODwyer D, Ashley S, Gurczynski S, Xia M, Wilke C, Falkowski N . Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019; 199(9):1127-1138. PMC: 6515865. DOI: 10.1164/rccm.201809-1650OC. View

Bellani G, Laffey J, Pham T, Fan E, Brochard L, Esteban A . Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016; 315(8):788-800. DOI: 10.1001/jama.2016.0291. View

Farrand E, Vittinghoff E, Ley B, Butte A, Collard H . Corticosteroid use is not associated with improved outcomes in acute exacerbation of IPF. Respirology. 2019; 25(6):629-635. DOI: 10.1111/resp.13753. View

Collard H, Moore B, Flaherty K, Brown K, Kaner R, King Jr T . Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2007; 176(7):636-43. PMC: 2094133. DOI: 10.1164/rccm.200703-463PP. View

Maher T, Whyte M, Hoyles R, Parfrey H, Ochiai Y, Mathieson N . Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique. Adv Ther. 2015; 32(10):929-43. PMC: 4635174. DOI: 10.1007/s12325-015-0249-6. View

Ranieri V, Rubenfeld G, Thompson B, Ferguson N, Caldwell E, Fan E . Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012; 307(23):2526-33. DOI: 10.1001/jama.2012.5669. View

Arai T, Inoue Y . Is corticosteroid use truly not associated with improved outcomes in AE-IPF?. Respirology. 2020; 25(6):659. DOI: 10.1111/resp.13826. View

Weng D, Chen X, Qiu H, Zhang Y, Li Q, Zhao M . The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Mediators Inflamm. 2019; 2019:5160694. PMC: 6335849. DOI: 10.1155/2019/5160694. View

10.

Kim D, Park J, Park B, Lee J, Nicholson A, Colby T . Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J. 2006; 27(1):143-50. DOI: 10.1183/09031936.06.00114004. View

11.

Hamman L, Rich A . Fulminating Diffuse Interstitial Fibrosis of the Lungs. Trans Am Clin Climatol Assoc. 2011; 51:154-63. PMC: 2242096. View

12.

Molyneaux P, Willis-Owen S, Cox M, James P, Cowman S, Loebinger M . Host-Microbial Interactions in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2017; 195(12):1640-1650. PMC: 5476909. DOI: 10.1164/rccm.201607-1408OC. View

13.

Arai T, Inoue Y . Corticosteroids in acute exacerbations of idiopathic interstitial pneumonias: Time to debate - Reply. Respirology. 2018; 23(5):546-547. DOI: 10.1111/resp.13278. View

14.

Churg A, Muller N, Silva C, Wright J . Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am J Surg Pathol. 2007; 31(2):277-84. DOI: 10.1097/01.pas.0000213341.70852.9d. View

15.

Ambrosini V, Cancellieri A, Chilosi M, Zompatori M, Trisolini R, Saragoni L . Acute exacerbation of idiopathic pulmonary fibrosis: report of a series. Eur Respir J. 2003; 22(5):821-6. DOI: 10.1183/09031936.03.00022703. View

16.

Valenzi E, Yang H, Sembrat J, Yang L, Winters S, Nettles R . Topographic heterogeneity of lung microbiota in end-stage idiopathic pulmonary fibrosis: the Microbiome in Lung Explants-2 (MiLEs-2) study. Thorax. 2020; 76(3):239-247. PMC: 8203183. DOI: 10.1136/thoraxjnl-2020-214770. View

17.

Kondoh Y, Taniguchi H, Kawabata Y, Yokoi T, Suzuki K, Takagi K . Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest. 1993; 103(6):1808-12. DOI: 10.1378/chest.103.6.1808. View

18.

Collard H, Ryerson C, Corte T, Jenkins G, Kondoh Y, Lederer D . Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report. Am J Respir Crit Care Med. 2016; 194(3):265-75. DOI: 10.1164/rccm.201604-0801CI. View

19.

Naccache J, Jouneau S, Didier M, Borie R, Cachanado M, Bourdin A . Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021; 10(1):26-34. DOI: 10.1016/S2213-2600(21)00354-4. View

20.

Jang H, Yong S, Leem A, Lee S, Kim S, Lee S . Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department. Sci Rep. 2021; 11(1):5762. PMC: 7952556. DOI: 10.1038/s41598-021-85539-1. View